IgG4-related cardiovascular disorders

International Heart Journal

Volumn 55, Issue 4, 2014, Pages 287-295

  Tajima, Miyu ^a,b   Nagai, Ryozo ^c   Hiroi, Yukio ^d  

^a UNIVERSITY OF TOKYO   (Japan)

^b SAKAKIBARA HEART INSTITUTE   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

^d NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

Aneurysm; Aortitis; Arteritis; Biopsy; Cardiovascular involvement; Corticosteroid; Pericarditis; Pseudotumor; Rupture

Indexed keywords

AZATHIOPRINE; BORTEZOMIB; BRAIN NATRIURETIC PEPTIDE; CHEMOKINE RECEPTOR CCR5; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 9; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RITUXIMAB;

ABDOMINAL AORTA ANEURYSM; ANEURYSM RUPTURE; AORTITIS; ARTICLE; AUTOIMMUNE PANCREATITIS; BIOPSY; CARDIOVASCULAR DISEASE; CD4+ T LYMPHOCYTE; COMPUTER ASSISTED TOMOGRAPHY; CONSTRICTIVE PERICARDITIS; CORONARY ARTERY ANEURYSM; CORTICOSTEROID THERAPY; DISEASE COURSE; ECHOCARDIOGRAPHY; HUMAN; IMMUNOGLOBULIN G4 RELATED DISEASE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY DISEASE; MIKULICZ DISEASE; PERICARDITIS; PRIORITY JOURNAL; RETROPERITONEAL FIBROSIS; SCINTIGRAPHY; SYSTEMIC LUPUS ERYTHEMATOSUS; THORACIC AORTA ANEURYSM;

ANTIBODIES, ANTI-IDIOTYPIC; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CARDIOVASCULAR DISEASES; HUMANS; IMMUNOGLOBULIN G;

EID: 84904098703     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.13-321     Document Type: Article

References (114)

1. Sato Y, Notohara K, Kojima M, Takata K, Masaki Y, Yoshino T. IgG4-related disease: Historical overview and pathology of hematological disorders. Pathol Int 2010; 60: 247-58. (Review)
2. Tajima M, Hiroi Y, Takazawa Y, et al. Immunoglobulin G4-related multiple systemic aneurysms and splenic aneurysm rupture during steroid therapy. Hum Pathol 2014; 45: 175-9.
3. Sarles H, Sarles JC, Muratore R, Guien C. Chronic inflammatory sclerosis of the pancreas--an autonomous pancreatic disease? Am J Dig Dis 1961; 6: 688-98.
4. Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 1995; 40: 1561-68. (Review)
5. Matsubayashi H, Sawai H, Kimura H, et al. Characteristics of autoimmune pancreatitis based on serum IgG4 level. Dig Liver Dis 2011; 43: 731-5.
6. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001; 344: 732-8.
7. Kawa S, Okazaki K, Kamisawa T, Shimosegawa T, Tanaka M. Japanese consensus guidelines for management of autoimmune pancreatitis: II. Extrapancreatic lesions, differential diagnosis. J Gastroenterol 2010; 45: 355-69.
8. Okazaki K, Uchida K, Koyabu M, Miyoshi H, Takaoka M. Recent advances in the concept and diagnosis of autoimmune pancreatitis and IgG4-related disease. J Gastroenterol 2011; 46: 277-88. (Review)
9. Zen Y, Harada K, Sasaki M, et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol 2004; 28: 1193-203.
10. Yamamoto M, Harada S, Ohara M, et al. Clinical and pathological differences between Mikulicz's disease and Sjögren's syndrome. Rheumatology(Oxford) 2005; 44: 227-34.
11. Zen Y, Sawazaki A, Miyayama S, Notsumata K, Tanaka N, Nakanuma Y. A case of retroperitoneal and mediastinal fibrosis exhibiting elevated levels of IgG4 in the absence of sclerosing pancreatitis (autoimmune pancreatitis). Hum Pathol 2006; 37: 239-43.
12. Watson SJ, Jenkins DA, Bellamy CO. Nephropathy in IgG4-related systemic disease. Am J Surg Pathol 2006; 30: 1472-7.
13. Yoneda K, Murata K, Katayama K, et al. Tubulointerstitial nephritis associated with IgG4-related autoimmune disease. Am J Kidney Dis 2007; 50: 455-62.
14. Joo M, Chang SH, Kim H, Lee KC, Ro JY. Idiopathic segmental ureteritis, misdiagnosed as ureteral cancer preoperatively: a case report with literature review. Pathol Int 2010; 60: 779-83. (Review)
15. Wong S, Lam WY, Wong WK, Lee KC. Hypophysitis presented as inflammatory pseudotumor in immunoglobulin G4-related systemic disease. Hum Pathol 2007; 38: 1720-3.
16. Nishimori I, Kohsaki T, Onishi S, et al. IgG4-related autoimmune prostatitis: two cases with or without autoimmune pancreatitis. Intern Med 2007; 46: 1983-9.
17. Kasashima S, Zen Y, Kawashima A, et al. Inflammatory abdominal aortic aneurysm: close relationship to IgG4-related periaortitis. Am J Surg Pathol 2008; 32: 197-204.
18. Ishida M, Hotta M, Kushima R, Asai T, Okabe H. IgG4-related inflammatory aneurysm of the aortic arch. Pathol Int 2009; 59: 269-73.
19. Stone JH, Khosroshahi A, Deshpande V, Stone JR. IgG4-related systemic disease accounts for a significant proportion of thoracic lymphoplasmacytic aortitis cases. Arthritis Care Res (Hoboken) 2010; 62: 316-22.
20. Takahashi M, Shimizu T, Inajima T, et al. A case of localized IgG4-related thoracic periarteritis and recurrent nerve palsy. Am J Med Sci 2011; 341: 166-9.
21. Kanno A, Satoh K, Kimura K, et al. Autoimmune pancreatitis with hepatic inflammatory pseudotumor. Pancreas 2005; 31: 420-3.
22. Kitagawa S, Zen Y, Harada K, et al. Abundant IgG4-positive plasma cell infiltration characterizes chronic sclerosing sialadenitis(Küttner's tumor). Am J Surg Pathol 2005; 29: 783-91.
23. Zen Y, Kitagawa S, Minato H, et al. IgG4-positive plasma cells in inflammatory pseudotumor (plasma cell granuloma) of the lung. Hum Pathol 2005; 36: 710-7.
24. Sugimoto T, Morita Y, Isshiki K, et al. Constrictive pericarditis as an emerging manifestation of hyper-IgG4 disease. Int J Cardiol 2008; 130: e100-1.
25. Matsumoto Y, Kasashima S, Kawashima A, et al. A case of multiple immunoglobulin G4-related periarteritis: a tumorous lesion of the coronary artery and abdominal aortic aneurysm. Hum Pathol 2008; 39: 975-80.
26. Ikutomi M, Matsumura T, Iwata H, et al. Giant tumorous legions(correction of legions) surrounding the right coronary artery associated with immunoglobulin-G4-related systemic disease. Cardiology 2011; 120: 22-6.
27. Takato H, Yasui M, Ichikawa Y, et al. Nonspecific interstitial pneumonia with abundant IgG4-positive cells infiltration, which was thought as pulmonary involvement of IgG4-related autoimmune disease. Intern Med 2008; 47: 291-4.
28. Yamamoto H, Yasuo M, Nomura Y, et al. IgG4-related airway involvement which developed in a patient receiving corticosteroid therapy for autoimmune pancreatitis. Intern Med 2011; 50: 3023-6.
29. Cheuk W, Yuen HK, Chan AC, et al. Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacryoadenitis: a previously undescribed complication of IgG4-related sclerosing disease. Am J Surg Pathol 2008; 32: 1159-67.
30. Chen TS, Montgomery EA. Are tumefactive lesions classified as sclerosing mesenteritis a subset of IgG4-related sclerosing disorders? J Clin Pathol 2008; 61: 1093-7.
31. Cheuk W, Chan AC, Lam WL, et al. IgG4-related sclerosing mastitis: description of a new member of the IgG4-related sclerosing diseases. Am J Surg Pathol 2009; 33: 1058-64.
32. Cho HK, Lee YJ, Chung JH, Koo JW. Otologic manifestation in IgG4-related systemic disease. Clin Exp Otorhinolaryngol 2011; 4: 52-4.
33. Lopes J, Hochwald SN, Lancia N, Dixon LR, Ben-David K. Autoimmune esophagitis: IgG4-related tumors of the esophagus. J Gastrointest Surg 2010; 14: 1031-4. (Review)
34. Fujita T, Ando T, Sakakibara M, Hosoda W, Goto H. Refractory gastric ulcer with abundant IgG4-positive plasma cell infiltration: a case report. World J Gastroenterol 2010; 16: 2183-6.
35. Umemura T, Zen Y, Hamano H, Kawa S, Nakanuma Y, Kiyosawa K. Immunoglobin G4-hepatopathy: association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis. Hepatology 2007; 46: 463-71.
36. Unno H, Saegusa H, Fukushima M, Hamano H. Usefulness of endoscopic observation of the main duodenal papilla in the diagnosis of sclerosing pancreatitis. Gastrointest Endosc 2002; 56: 880-4.
37. Dahlgren M, Khosroshahi A, Nielsen GP, Deshpande V, Stone JH. Riedel's thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum. Arthritis Care Res (Hoboken) 2010; 62: 1312-8.
38. Kojima M, Hirokawa M, Kuma H, et al. Distribution of IgG4-and/or IgG-positive plasma cells in Hashimoto's thyroiditis: an immunohistochemical study. Pathobiology 2010; 77: 267-72.
39. Moteki H, Yasuo M, Hamano H, Uehara T, Usami S. IgG4-related chronic rhinosinusitis: a new clinical entity of nasal disease. Acta Otolaryngol 2011; 131: 518-26.
40. Tamai R, Hasegawa Y, Hisano S, Miyake K, Nakashima H, Saito T. A case of IgG4-related tubulointerstitial nephritis concurrent with Henoch-Schönlein purpura nephritis. Allergy Asthma Clin Immunol 2011; 7: 5.
41. Saeki T, Ito T, Youkou A, et al. Thrombotic thrombocytopenic purpura in IgG4-related disease with severe deficiency of ADAMTS-13 activity and IgG4 autoantibody against ADAMTS-13. Arthritis Care Res(Hoboken) 2011; 63: 1209-12.
42. Cheuk W, Lee KC, Chong LY, Yuen ST, Chan JK. IgG4-related sclerosing disease: a potential new etiology of cutaneous pseudolymphoma. Am J Surg Pathol 2009; 33: 1713-9.
43. Zen Y, Kasahara Y, Horita K, et al. Inflammatory pseudotumor of the breast in a patient with a high serum IgG4 level: histologic similarity to sclerosing pancreatitis. Am J Surg Pathol 2005; 29: 275-8.
44. Zen Y, Kitagawa S, Minato H, et al. IgG4-positive plasma cells in inflammatory pseudotumor (plasma cell granuloma) of the lung. Hum Pathol 2005; 36: 710-7.
45. Bruneval P. Coronary artery pseudotumor: IgG4-related disease versus localized castleman disease. Hum Pathol 2009; 40: 279-80.
46. Shoji S, Nakano M, Usui Y. IgG4-related inflammatory pseudotumor of the kidney. Int J Urol 2010; 17: 389-90.
47. Katsura M, Morita A, Horiuchi H, Ohtomo K, Machida T. IgG4-related inflammatory pseudotumor of the trigeminal nerve: another component of IgG4-related sclerosing disease? AJNR Am J Neuroradiol 2011; 32: E150-2.
48. Bösmüller H, von Weyhern CH, Adam P, Alibegovic V, Mikuz G, Fend F. Paratesticular fibrous pseudotumor--an IgG4-related disorder? Virchows Arch 2011; 458: 109-13.
49. Umehara H, Okazaki K, Masaki Y, et al. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol 2012; 22: 1-14. (Review)
50. Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 2003; 38: 982-4.
51. Kamisawa T. IgG4-related sclerosing disease. Intern Med 2006; 45: 125-6.
52. Masaki Y, Dong L, Kurose N, et al. Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis 2009; 68: 1310-5.
53. Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med 2012; 366: 539-51. (Review)
54. Aalberse RC, Stapel SO, Schuurman J, Rispens T. Immunoglobulin G4: an odd antibody. Clin Exp Allergy 2009; 39: 469-77. (Review)
55. Robinson DS, Larché M, Durham SR. Tregs and allergic disease. J Clin Invest 2004; 114: 1389-97. (Review)
56. Jeannin P, Delneste Y, Lecoanet-Henchoz S, Gretener D, Bonnefoy JY. Interleukin-7 (IL-7) enhances class switching to IgE and IgG4 in the presence of T cells via IL-9 and SCD23. Blood 1998; 91: 1355-61.
57. Meiler F, Klunker S, Zimmermann M, Akdis CA, Akdis M. Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and toll-like receptors. Allergy 2008; 63: 1455-63.
58. Taguchi M, Kihara Y, Nagashio Y, Yamamoto M, Otsuki M, Harada M. Decreased production of immunoglobulin M and A in autoimmune pancreatitis. J Gastroenterol 2009; 44: 1133-39.
59. Okazaki K, Uchida K, Koyabu M, Miyoshi H, Takaoka M. Recent advances in the concept and diagnosis of autoimmune pancreatitis and IgG4-related disease. J Gastroenterol 2011; 46: 277-88. (Review)
60. Sakamoto A, Ishizaka N, Imai Y, Nagai R. Serum levels of IgG4 and soluble interleukin-2 receptor in patients with abdominal and thoracic aortic aneurysm who undergo coronary angiography. Atherosclerosis 2012; 221: 602-3.
61. Sakane K, Shibata K, Fujita SI, et al. Association between serum immunoglobulin G4 concentration and cardiac function among elderly cardiology inpatients. Geriatr Gerontol Int in press
62. Boiardi L, Vaglio A, Nicoli D, et al. CC chemokine receptor 5 polymorphism in chronic periaortitis. Rheumatology(Oxford) 2011; 50: 1025-32.
63. Vaglio A, Pipitone N, Salvarani C. Chronic periaortitis: a largevessel vasculitis? Curr Opin Rheumatol 2011; 23: 1-6. (Review)
64. Sun J, Sukhova GK, Yang M, et al. Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice. J Clin Invest 2007; 117: 3359-68.
65. Zhang J, Sun J, Lindholt JS, et al. Mast cell tryptase deficiency attenuates mouse abdominal aortic aneurysm formation. Circ Res 2011; 108: 1316-27.
66. Kasashima S, Zen Y. IgG4-related inflammatory abdominal aortic aneurysm. Curr Opin Rheumatol 2011; 23: 18-23. (Review)
67. Kasashima S, Zen Y, Kawashima A, et al. A clinicopathologic study of immunoglobulin G4-related sclerosing disease of the thoracic aorta. J Vasc Surg 2010; 52: 1587-95.
68. Inoue D, Zen Y, Abo H, et al. Immunoglobulin G4-related periaortitis and periarteritis: CT findings in 17 patients. Radiology 2011; 261: 625-33.
69. Raparia K, Molina CP, Quiroga-Garza G, Weilbaecher D, Ayala AG, Ro JY. Inflammatory aortic aneurysm: possible manifestation of IgG4-related sclerosing disease. Int J Clin Exp Pathol 2013; 6: 469-75.
70. Ishizaka N, Sohmiya K, Miyamura M, et al. Infected aortic aneurysm and inflammatory aortic aneurysm--in search of an optimal differential diagnosis. J Cardiol 2012; 59: 123-31. (Review)
71. Kanemitsu S, Shimono T, Nakamura A, Yamamoto K, Wada H, Shimpo H. Molecular diagnosis of nonaneurysmal infectious aortitis. J Vasc Surg 2011; 53: 472-4.
72. Agaimy A, Weyand M, Strecker T. Inflammatory thoracic aortic aneurysm (lymphoplasmacytic thoracic aortitis): a 13-year-experience at a German Heart Center with emphasis on possible role of IgG4. Int J Clin Exp Pathol 2013; 6: 1713-22.
73. Kasashima S, Zen Y, Kawashima A, Endo M, Matsumoto Y, Kasashima F. A new clinicopathological entity of IgG4-related inflammatory abdominal aortic aneurysm. J Vasc Surg 2009; 49: 1264-71.
74. Nitecki SS, Hallett JW Jr, Stanson AW, et al. Inflammatory abdominal aortic aneurysms: a case-control study. J Vasc Surg 1996; 23: 860-8.
75. Qian Q, Kashani KB, Miller DV. Ruptured abdominal aortic aneurysm related to IgG4 periaortitis. N Engl J Med 2009; 361: 1121-3.
76. Henderson EL, Geng YJ, Sukhova GK, Whittemore AD, Knox J, Libby P. Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms. Circulation 1999; 99: 96-104.
77. Trinidad-Hernandez M, Duncan AA. Contained ruptured paravisceral aortic aneurysm related to immunoglobulin G4 aortitis. Ann Vasc Surg 2012; 26: 108. e1-4.
78. Elefteriades JA. Natural history of thoracic aortic aneurysms: indications for surgery, and surgical versus nonsurgical risks. Ann Thorac Surg 2002; 74: S1877-80.
79. United Kingdom Small Aneurysm Trial Participants. Long-term outcomes of immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med 2002; 346: 1445-52.
80. Choke E, Cockerill G, Wilson WR, et al. A review of biological factors implicated in abdominal aortic aneurysm rupture. Eur J Vasc Endovasc Surg 2005; 30: 227-44. (Review)
81. Stenbaek J, Kalin B, Swedenborg J. Growth of thrombus may be a better predictor of rupture than diameter in patients with abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2000; 20: 466-9.
82. Tang T, Boyle JR, Dixon AK, Varty K. Inflammatory abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2005; 29: 353-62. (Review)
83. Gornik HL, Creager MA. Aortitis. Circulation 2008; 117: 3039-51 (Review)
84. Pacini D, Leone O, Turci S, et al. Incidence, etiology, histologic findings, and course of thoracic inflammatory aortopathies. Ann Thorac Surg 2008; 86: 1518-23.
85. Sakamoto A, Nagai R, Saito K, et al. Idiopathic retroperitoneal fibrosis, inflammatory aortic aneurysm, and inflammatory pericarditis--retrospective analysis of 11 case histories. J Cardiol 2012; 59: 139-46.
86. Bahler C, Hammoud Z, Sundaram C. Mediastinal fibrosis in a patient with idiopathic retroperitoneal fibrosis. Interact Cardiovasc Thorac Surg 2008; 7: 336-8. (Review)
87. Corradi D, Maestri R, Palmisano A, et al. Idiopathic retroperitoneal fibrosis: clinicopathologic features and differential diagnosis. Kidney Int 2007; 72: 742-53.
88. Laco J, Podhola M, Kamarádová K, et al. Idiopathic vs. Secondary retroperitoneal fibrosis: a clinicopathological study of 12 cases, with emphasis to possible relationship to IgG4-related disease. Virchows Arch 2013; 463: 721-30.
89. Vaglio A, Salvarani C, Buzio C. Retroperitoneal fibrosis. Lancet 2006; 367: 241-51. (Review)
90. Hamano H, Kawa S, Ochi Y, et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet 2002; 359: 1403-4.
91. Urabe Y, Fujii T, Kurushima S, Tsujiyama S, Kihara Y. Pigs-in-ablanket coronary arteries: a case of immunoglobulin G4-related coronary periarteritis assessed by computed tomography coronary angiography, intravascular ultrasound, and positron emission tomography. Circ Cardiovasc Imaging 2012; 5: 685-7.
92. Tanigawa J, Daimon M, Murai M, Katsumata T, Tsuji M, Ishizaka N. Immunoglobulin G4-related coronary periarteritis in a patient presenting with myocardial ischemia. Hum Pathol 2012; 43: 1131-4.
93. Masaki Y, Kurose N, Umehara H. IgG4-related disease: a novel lymphoproliferative disorder discovered and established in Japan in the 21st century. J Clin Exp Hematop 2011; 51: 13-20. (Review)
94. Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol 2012; 22: 21-30.
95. Okazaki K, Uchida K, Miyoshi H, Ikeura T, Takaoka M, Nishio A. Recent concepts of autoimmune pancreatitis and IgG4-related disease. Clin Rev Allergy Immunol 2011; 41: 126-38. (Review)
96. Nguyen VX, De Petris G, Nguyen BD. Usefulness of PET/CT imaging in systemic IgG4-related sclerosing disease. A report of three cases. JOP 2011; 12: 297-305.
97. Ishii S, Shishido F, Miyajima M, Sakuma K, Shigihara T, Kikuchi K. Whole-body gallium-67 scintigraphic findings in IgG4-related disease. Clin Nucl Med 2011; 36: 542-5.
98. Nakatani K, Nakamoto Y, Togashi K. Utility of FDG PET/CT in IgG4-related systemic disease. Clin Radiol 2012; 67: 297-305. (Review)
99. Tsushima K, Tanabe T, Yamamoto H, et al. Pulmonary involvement of autoimmune pancreatitis. Eur J Clin Invest 2009; 39: 714-22.
100. Nakajo M, Jinnouchi S, Fukukura Y, Tanabe H, Tateno R. The efficacy of whole-body FDG-PET or PET/CT for autoimmune pancreatitis and associated extrapancreatic autoimmune lesions. Eur J Nucl Med Mol Imaging 2007; 34: 2088-95.
101. Ebbo M, Grados A, Guedj E, et al. 18F-FDG PET/CT for staging and evaluation of treatment response in IgG4-related disease: a retrospective multicenter study. Arthritis Care Res (Hoboken) 2014; 66: 86-96.
102. Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 2003; 38: 982-4.
103. Kamisawa T, Okamoto A. Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease. J Gastroenterol 2006; 41: 613-25. (Review)
104. Hamano H, Arakura N, Muraki T, Ozaki Y, Kiyosawa K, Kawa S. Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. J Gastroenterol 2006; 41: 1197-205.
105. Kusumoto S, Kawano H, Takeno M, et al. Mass lesions surrounding coronary artery associated with immunoglobulin G4-related disease. J Cardiol Cases 2012; 5: e150-4.
106. Puchner S, Bucek RA, Loewe C, et al. Endovascular repair of inflammatory aortic aneurysms: Long-term results. AJR Am J Roentgenol 2006; 186: 1144-7.
107. Kamisawa T, Takuma K, Hara S, et al. Management strategies for autoimmune pancreatitis. Expert Opin Pharmacother 2011; 12: 2149-59. (Review)
108. Tabata T, Kamisawa T, Takuma K, et al. Serial changes of elevated serum IgG4 levels in IgG4-related systemic disease. Intern Med 2011; 50: 69-75.
109. Pezzilli R, Cariani G, Santini D, et al. Therapeutic management and clinical outcome of autoimmune pancreatitis. Scand J Gastroenterol 2011; 46: 1029-38.
110. Kamisawa T, Shimosegawa T, Okazaki K, et al. Standard steroid treatment for autoimmune pancreatitis. Gut 2009; 58: 1504-7.
111. Kubota K, Iida H, Fujisawa T, et al. Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis. Gastrointest Endosc 2007; 66: 1142-51.
112. Khosroshahi A, Stone JH. Treatment approaches to IgG4-related systemic disease. Curr Opin Rheumatol 2011; 23: 67-71. (Review)
113. Sakata N, Tashiro T, Uesugi N, et al. IgG4-positive plasma cells in inflammatory abdominal aortic aneurysm: the possibility of an aortic manifestation of IgG4-related sclerosing disease. Am J Surg Pathol 2008; 32: 553-9.
114. Stone WM, Fankhauser GT, Bower TC, et al. Comparison of open and endovascular repair of inflammatory aortic aneurysms. J Vasc Surg 2012; 56: 951-5.